Infectio Diagnostic Inc.
This article was originally published in Start Up
Executive Summary
Current microbial diagnostics take two to three days to identify infectious agents. During that time, patients in hospitals might not receive the appropriate treatment, or might infect others with antibiotic-resistant microbes. Infectio Diagnostic is developing a rapid DNA diagnostic that will be able to identify infecious microbes in under an hour.
You may also be interested in...
Hospital-Based Infections
Physicians and hospitals are concerned about the problem of hospital-acquired infections, as is the US Centers for Disease Control, which has launched a campaign to prevent antimicrobial resistance in health care settings. Start-ups believe they can help, with effective and rapid tests for infectious disease and narrow spectrum antimicrobials targeted to specific pathogens. buhed ehnwhihOntros sion, acarel
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.